PTPN2/1 inhibitors (Centre for Drug Design and Discovery/University of Zurich)

N/A

Report date: 2025/01/26 17:49:13
NME

Base Information

Drug NamePTPN2/1 inhibitors (Centre for Drug Design and Discovery/University of Zurich)
Drug Alias Namedual protein tyrosine phosphatase nonreceptor type 2/1 inhibitors (Centre for Drug Design and Discovery/University of Zurich)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein phosphatase non-receptor type 2 inhibitorsProtein-tyrosine phosphatase 1B inhibitors
TargetsTyrosine-protein phosphatase non-receptor type 2Protein-tyrosine phosphatase 1B
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumSwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Zurich
China Registration ClassN/A

Develop Information

Active CompaniesKU Leuven’s Centre for Drug Design and DiscoveryUniversity of Zurich
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A